Follow the CHEMBIO DIAGNOSTICS, INC. share price and the full management transaction log of the company, a listed issuer based in United States. Shares are quoted on the US market, under the oversight of SEC (Form 4). Market capitalisation: €2.2bn. The latest transaction was filed on 2 May 2023 (Retenue fiscale). Among the most active insiders: Angelico Paul. All data is openly available.
21
Insider Decl.
n/a
Thresholds
€222,810
5 ops.
Buy Volume
n/a
n/a
Sell Volume
Analyst consensus: bullish or bearish?
Analysts rate CHEMBIO DIAGNOSTICS, INC. Strong Buy (bullish), based on 12 analysts. Average price target: US$59.30.
16Σ signal
Buys €222,810n/a Sells
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental score
Ranked 26,986 of 29,053 companies
18.5
score / 100
Value
23
Quality
15
FCF yld-4.0%
Earn yld-5.1%
EV/EBITDA·
ROE-40%
Gross mgn17%
Net mgn·
Debt/EBITDA·
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
195,938 shares@ US$0.443.4% of flowCommon StockSEC:0000899243-23-010947:0
Canonical exit: 3 Jul 2023 (T+90)
21 of 21 declarations
About CHEMBIO DIAGNOSTICS, INC.
CHEMBIO DIAGNOSTICS, INC. is a company focused on developing diagnostic tests for infectious diseases. It is listed on the NASDAQ under the symbol CEMI.